From Point Solutions to Enterprise Value: How ClaimVise.ai Fits PwC's Revenue Cycle AI Framework
A faster denial letter does not fix a slow revenue cycle.
Chirag Shah, Founder, ClaimVise.ai ·
PwC made that point in a November 2026 article on AI in revenue cycle, and it matches what I see building ClaimVise.ai every week.
Their example is a simple one. An AI tool drafts a denial appeal in seconds. But someone still has to find the record, check the letter, log in to the payer portal, submit it and update the account. One step got faster. The workflow stayed the same.
PwC's conclusion is that health systems now have to prove AI delivers value, not just that it works. Below is how I read their framework, and how we built ClaimVise.ai around the same ideas.
PwC's framework in four steps
PwC estimates that coordinated, end-to-end redesign can produce upwards of 60% efficiency gains, 5% net revenue uplift from reduced leakage and 50% cost savings. They are careful to say these outcomes are not automatic. They depend on your technology landscape, which workflows you pick, how far you scale, how your workforce needs change, how ready your organization is and what you do with the capacity that gets freed up.
They say providers miss the return for three reasons. They choose the tool before they have sized the opportunity. They change the task but not the workflow or the roles around it. And nobody owns performance after go-live. Their answer is four steps:
- Size the opportunity. Find where labor, vendor spend, backlog and revenue leakage (denial write-offs and underpayments, for example) pile up, and set a baseline, before you pick a tool.
- Redesign the workflow first. Remove handoffs. Then decide what AI does on its own, what a person validates and who owns the exceptions.
- Assess what you already have, then build shared infrastructure. Use your EHR's native features where they meet the need or soon will. Add outside or custom tools where they clearly fill a gap, and baseline each one so you can tell which one produced which result. Shared data, payer rules, access controls and audit trails should let all of it work together, without custom builds that are hard to unwind later.
- Create accountability. A Value Realization Office tracks results against the business case and steps in when value lags.
Source: PwC, "AI in Revenue Cycle: From Point Solutions to Enterprise Value", November 12, 2026.
Where ClaimVise.ai fits each step
We designed ClaimVise.ai as a workflow, not a feature. This table maps each PwC step to what is in the platform today.
| PwC step | What PwC asks for | What ClaimVise.ai does |
|---|---|---|
| Size the opportunity | Measure the financial impact before you automate | Every night the billing scorecard compares each claim three ways: as ClaimVise coded it, as your reviewer finalized it and as the practice charged it. Baselines for each practice are the next layer (see "Where things stand" below). |
| Redesign the workflow | Remove handoffs and define what AI does and what a person does | One pipeline from clinical note to coded claim. Secure connectors handle chart retrieval, eligibility checks and charge posting, so those manual handoffs go away. A person reviews every claim before it is posted or exported. |
| Shared infrastructure | Use what exists, add tools only where they fill real gaps, and share payer rules, access controls and audit trails | The connectors work inside the systems a practice already uses (OncoEMR and AdvancedMD today) instead of replacing them. The scorecard's three-way comparison shows how our coding compares with what your reviewers and the practice finally billed. Billing policy is layered: system defaults, then specialty rules, then your billing agency, then the practice, then the payer. Payer rules always win over practice preferences. Every action is written to an audit log, and AI processing runs on AWS Bedrock under an executed BAA. |
| Accountability | Track results against the business case and step in when value falls short | A scorecard history for each claim, usage and wallet metering, and a recode audit trail that shows what changed and when. |
The point of the layering is that a payer's rule is written once and applies to every practice that bills that payer. Nobody has to re-fix it practice by practice.
What about your EHR's own AI features? PwC's advice is to use native EHR capabilities where they meet your needs today or are about to. We agree. ClaimVise.ai is not an EHR or a practice management system, and it does not replace one. It works inside the ones practices already use. Start by listing what your EHR already does and plans to do. Where it covers a step well, use it. Where a gap remains, test us there, and baseline both so you can see which one produced which result.
Governance in practice: shadow first, human sign-off, no surprises
PwC's sharpest point is that someone has to decide what AI does alone and what a person validates. Here is how we handle that when a new specialty reaches production. There are four rules.
- Shadow mode first. New specialty rules run beside the live coding path and record what they would have done. What gets billed never changes, so a practice sees the evidence before anything moves.
- A qualified coder signs off the rules. Each set of rules comes with a rules document and open questions for a certified coder. Until a coder signs it off, it stays in shadow.
- Flag, don't guess. When a rule can't be checked, say because the payer is ambiguous, the system records that the check did not run. It does not invent an answer.
- Isolation by design. An automated check confirms that a new specialty branch touches only its own files. Adding a specialty can't quietly change how oncology claims are coded.
We apply the same discipline to maintenance. We found that valid ICD-10 codes with a letter in the third character, such as Z3A, were being rejected. The fix has its own 51-test suite, and it is held until we replay a set of stored notes through it. Only then does it go to production. PwC calls this "refreshing payer rules and business logic" and says someone has to own it. For us, that owner is written into the release process.
Where things stand
PwC's own caution applies to us too: value has to be measured, not assumed. So here is an honest picture as of November 2026.
| Area | Status |
|---|---|
| Coding, billing scorecard, OncoEMR chart retrieval, eligibility checks and AdvancedMD charge posting | Live with a billing-agency client, mainly in hematology and oncology infusion billing. |
| Specialty rules beyond hematology and oncology | One set is in production, in shadow only, waiting for a qualified coder's sign-off. More are built in code and not yet released. All of them start in shadow. |
| Remittance (835) file reading | Built. No real remittance file has been run through it yet. |
| ICD-10 fix for codes with a letter in the third character | Built and tested. Waiting on the stored-notes replay before release. |
| Baselines for each practice and a value view (denial rate, clean-claim rate, recovered underpayments) | Planned. This is next, so each practice can see its own before and after. |
We are not publishing savings percentages in this article. Our base of real claims is still small, and PwC's own figures are estimates that depend on how the work is done, not guarantees. When we have measured results for a practice, we will share them along with the method.
Work with us
If you run a practice, a billing agency or an RCM team and want to test AI the way PwC recommends, we would like to talk. Start with one workflow. Measure it against your own baseline. Expand only where the numbers hold.
Reach out and we will show you how it works on a sample note, and how a new specialty is rolled out in shadow before anything changes in your billing.
Contact: chirag@innodel.com · Book a demo · claimvise.ai